ImmunityBio, Inc. financial data

Symbol
IBRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
3530 John Hopkins Court, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
NantKwest, Inc. (to 3/8/2021), Conkwest, Inc. (to 7/13/2015), ZelleRx Corp (to 10/9/2009)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 94.6 % +179%
Debt-to-equity -170 % +3.54%
Return On Equity 103 % +9.77%
Return On Assets -148 % -18.1%
Operating Margin -115K % -82.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 674M shares +54.6%
Common Stock, Shares, Outstanding 677M shares +60.6%
Entity Public Float 316M USD +4.57%
Common Stock, Value, Issued 68K USD +58.1%
Weighted Average Number of Shares Outstanding, Basic 673M shares +57.1%
Weighted Average Number of Shares Outstanding, Diluted 673M shares +57.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 302K USD -48.5%
Research and Development Expense 206M USD -24.1%
Operating Income (Loss) -346M USD +5.73%
Nonoperating Income (Expense) -256M USD -300%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -601M USD -39.6%
Income Tax Expense (Benefit) -40K USD -218%
Net Income (Loss) Attributable to Parent -601M USD -39.7%
Earnings Per Share, Basic -1.08 USD/shares -2.86%
Earnings Per Share, Diluted -1.08 USD/shares -2.86%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 133M USD +50.4%
Marketable Securities, Current 37.5M USD +1244%
Other Assets, Current 2.58M USD -41.8%
Assets, Current 196M USD +72.5%
Property, Plant and Equipment, Net 144M USD -6.91%
Operating Lease, Right-of-Use Asset 35.2M USD -20.4%
Intangible Assets, Net (Excluding Goodwill) 16.6M USD -15%
Other Assets, Noncurrent 2.73M USD -40%
Assets 401M USD +16.7%
Accounts Payable, Current 33.6M USD +241%
Accrued Liabilities, Current 32.7M USD -39.6%
Liabilities, Current 53.8M USD -90.5%
Deferred Income Tax Liabilities, Net 162K USD -4.71%
Operating Lease, Liability, Noncurrent 38.2M USD -17.5%
Other Liabilities, Noncurrent 1.29M USD +178%
Liabilities 1.09B USD +24.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7K USD +78.8%
Retained Earnings (Accumulated Deficit) -3.1B USD -24.1%
Stockholders' Equity Attributable to Parent -692M USD -30.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -691M USD -30%
Liabilities and Equity 401M USD +16.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -107M USD -26.9%
Net Cash Provided by (Used in) Financing Activities 10.2M USD -86.7%
Net Cash Provided by (Used in) Investing Activities -35.6M USD -320%
Common Stock, Shares Authorized 1.35B shares +50%
Common Stock, Shares, Issued 677M shares +55.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -132M USD -719%
Interest Paid, Excluding Capitalized Interest, Operating Activities 23.9M USD +54.1%
Deferred Tax Assets, Valuation Allowance 648M USD +31.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 683M USD +30.4%
Operating Lease, Liability 44.3M USD -9.88%
Depreciation 16.3M USD -2.4%
Payments to Acquire Property, Plant, and Equipment 1.26M USD -85%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -601M USD -15.1%
Lessee, Operating Lease, Liability, to be Paid 60.9M USD -16.3%
Property, Plant and Equipment, Gross 232M USD +1.9%
Operating Lease, Liability, Current 6.08M USD +114%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.98M USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.9M USD -10.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Deferred Income Tax Expense (Benefit) -4K USD +50%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 15.9M USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.22M USD -20.1%
Deferred Tax Assets, Operating Loss Carryforwards 421M USD +16.1%
Deferred Federal Income Tax Expense (Benefit) -5K USD -150%
Current Income Tax Expense (Benefit) -26K USD -168%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 35.5M USD +118%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.47M USD +3.12%
Operating Lease, Payments 2.38M USD -25%
Current State and Local Tax Expense (Benefit) -26K USD -168%
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 2M USD -4.76%
Depreciation, Depletion and Amortization 4.56M USD -2.69%
Share-based Payment Arrangement, Expense 46.6M USD +13.4%
Deferred State and Local Income Tax Expense (Benefit) -9K USD -350%
Interest Expense 129M USD +51.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%